Amgen to Buy Celgene’s Otezla for $13.4 Billion in Cash

◊ Amgen News Today ◊ ♦ Amgen Buy Otezla ♦ Stock Market News ♦ … — Amgen Inc. said it has agreed to buy Celgene Corp. ’s psoriasis treatment Otezla for $13.4 billion in cash, in a deal that would pave the way for Bristol-Myers Squibb Co. to complete its acquisition of Celgene. Amgen said Monday […]

Read More…